UMIN ID: UMIN000000781
Registered date:01/08/2007
Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | non-small cell lung cancer |
Date of first enrollment | 2007/08/01 |
Target sample size | 120 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | adjuvant chemotherapy with CBDCA+GEM adjuvant chemotherapy with TS1+DTX |
Outcome(s)
Primary Outcome | 2-year relapse free survival |
---|---|
Secondary Outcome | toxicity |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 76years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | symptomatic interstitial pneumonia multiple lung cancer or other-type cancer within 5 years severe organ failure past history of radiotherapy or chemotherapy pregnant or expecting mother |
Related Information
Primary Sponsor | Japanese Northern East Area Thoracic Surgery Study Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
Secondary ID(s) |
Contact
public contact | |
Name | Chiaki Endo |
Address | 4-1Seiryo-machi, Aoba-ku, Sendai Japan |
Telephone | 022-717-8526 |
endo@idac.tohoku.ac.jp | |
Affiliation | Japanese Northern East Area Thoracic Surgery Study Group Central study center |
scientific contact | |
Name | Takao Tsushima |
Address | 53Honcho, Hirosaki, Aomori Japan |
Telephone | 0172-39-5074 |
tsusim@cc.hirosaki-u.ac.jp | |
Affiliation | Hirosaki University Hospital Department of Thoracic Surgery |